A free webinar, “Preventing Cognitive Decline at Late-Life,” will be hosted by the Institute for Mental Health Research (IMHR) September 9. Jordan Karp, MD, a member of the IMHR Scientific Advisory Council, who is an internationally-recognized geriatric psychiatrist, professor and chair of the Department of Psychiatry at the College of Medicine – Tucson, will share his research on cognitive decline.

Melanie L. Bell, Ph.D., from the University of Arizona in Tucson and colleagues estimated the prevalence of post-acute sequelae of COVID-19 (PASC) -- defined as experiencing at least one symptom ≥30 days – and the prevalence of individual symptoms among 303 non-hospitalized individuals with a positive lab-confirmed COVID-19 test and mild or moderate disease with follow-up for a median 61 days.

Understanding your emotions and a willingness to adjust after months of social distancing are key to a successful return.

COVID-19 hospitalizations continue to rise in Iowa, and among the health care workers who have been vital to caring for the sickest patients are nurses. Now just about a year and a half into the pandemic, many are at risk of burning out. "We, for so long, have really shied away from making legislation about staffing, for example, and really trying to address burnout," said Jessica Rainbow, PhD, RN, an assistant professor in the College of Nursing.

A University of Arizona Cancer Center-based program fosters the next generation of Native American scientists and doctors.

A new study led by the University of Arizona College of Nursing will examine the prevalence of cannabis and other substance use in nurses who may work through significant pain and be at risk for substance abuse.

In his latest COVID-19 Update and Forecast published on Saturday, Joe Gerald, MD, PhD, associate professor of public health policy and management with the Mel and Enid Zuckerman College of Public Health, predicted that hospitals would experience reductions in services. “Undoubtedly, some medically necessary procedures will likely be postponed and rescheduled over the coming weeks to make room for critically ill COVID-19 patients,” said Dr. Gerald.

Joe Gerald, MD, PhD, an associate professor of public health policy and management at the Mel and Enid Zuckerman College of Public Health, says COVID-19 conditions in the state of Arizona are getting worse and could reach a peak by the end of the month.

Continuing coverage: University of Arizona Health Sciences researchers have developed a new therapy for Alzheimer’s disease designed to restore cognitive function in early-stage patients. The therapy is now proceeding through a Phase 2b clinical trial. Roberta Diaz Brinton, PhD, director of the UArizona Center for Innovation in Brain Science, is the lead investigator.